|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| C07D 239/42 | (2013.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61K 31/505 | (2013.01) | ||
| A61K 47/00 | (2006.01) | ||
| A61K 31/517 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 31/5377 | (2006.01) | ||
| C07D 239/42 | (2006.01) |
| (11) | Patento numeris | 3054952 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14851657.8 |
| Europos patento paraiškos padavimo data | 2014-10-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/059238 |
| Data | 2014-10-06 |
| (87) | Numeris | WO 2015/054099 |
| Data | 2015-04-16 |
| (30) | Numeris | Data | Šalis |
| 201361888207 P | 2013-10-08 | US |
| (72) |
TAMANG, David Lee , US
YANG, Min , US
JONES, Simon S. , US
|
| (73) |
Acetylon Pharmaceuticals, Inc. ,
70 Fargo Street, Suite 205, Boston, MA 02210,
US
|
| (54) | COMBINATIONS OF HISTONE DEACETYLASE 6 INHIBITORS AND THE HER2 INHIBITOR LAPATINIB FOR USE IN THE TREATMENT OF BREAST CANCER |
| COMBINATIONS OF HISTONE DEACETYLASE 6 INHIBITORS AND THE HER2 INHIBITOR LAPATINIB FOR USE IN THE TREATMENT OF BREAST CANCER |